Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
about
American Cancer Society Head and Neck Cancer Survivorship Care GuidelineSolid tumor second primary neoplasms: who is at risk, what can we do?Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma.Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors.Second primary tumors in patients with head and neck cancer.Evaluation of optical coherence tomography to discriminate lesions of the upper aerodigestive tract.High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancerAnatomic sites at elevated risk of second primary cancer after an index head and neck cancer.The effect of patient characteristics on second primary cancer risk in France.Clinical significance of early detection of esophageal cancer in patients with head and neck cancerTotal and partial cancer prevalence in the adult French population in 2008Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.Incidence and prognostic significance of second primary cancers in renal cell carcinoma.Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results DatabaseChemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesElectronic Cigarette: Role in the Primary Prevention of Oral Cavity Cancer.Determinants of outcome following surgery for oral squamous cell carcinoma.The clinical characteristics of secondary primary tumors in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: A retrospective analysis.A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study.Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.Squamous cell carcinoma and precursor lesions: clinical pathology.Surgical strategies for esophageal cancer associated with head and neck cancer.Head and neck mucoepidermoid carcinoma: a curious association with second primary malignancy.Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.Risk of Second Primary Cancer in People with Non-Melanoma Skin Cancer: A Nationwide Cohort Study.Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.Outcomes of microvascular free tissue transfer in twice-irradiated patients.Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence.Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: Experience of a French evaluation cooperative subgroup of GETTEC.A Challenging Picture of Cancer-and Inflammation-Related Changes.
P2860
Q26752802-09496B14-7F21-4C11-A180-1871C859167AQ27026266-6093325F-A4A2-4CD2-A3DA-A8048CD4A45AQ30661506-D62C7E0C-B020-4B31-94DA-956E17D3965AQ31105108-2E745610-7167-48CA-A0D2-FAC66C81C91AQ33853975-B504CDD4-4BCA-4357-ADA8-7C069B1BE28BQ33933926-BBF9372D-50A9-4629-BC7B-149F214667AEQ34139683-17A9CABD-B2D2-4BE3-969D-E370A804690EQ34158978-8DF129BF-F257-49EA-86BD-7025E0AB0943Q34460008-1291E650-1D42-4D37-A5EE-8123CA7481A1Q34567607-D84D6FDB-416C-42E8-B0FC-994D46ADD9F9Q34667840-16742C01-4CBF-4F33-B4B9-4EC2E80A886DQ34892580-022C128F-7A16-4985-8662-2BF98FB9F694Q35094581-89E30952-CB99-4332-8881-A0B0CA874B73Q35151757-D05BBF0A-6937-4037-8444-6C6ED2B452A8Q35204233-4ECE4C04-1C98-43B4-A0F8-FD77D997962CQ35738663-397E5291-0372-4250-A79E-19A932850DF4Q36060549-7FB081BD-3439-4004-A290-8EF7C03ED9CFQ36612435-B8DDFA90-4450-44C4-951C-D957E3620987Q36757760-3DCEC848-D566-4CCC-8244-494B0AF1135AQ37111529-D00F6A06-A889-4161-B162-13DC37B359C3Q37347262-954B5C34-DA98-4B23-AEEC-94660C4FEBFCQ37401334-54DE7E6C-CD2F-45F0-BBA8-8A8538911D56Q37409586-AD421330-7D35-46B4-AE72-663EFCAFE029Q37497976-31A54E3E-F49E-4EBF-B820-976F1C7262E8Q37541615-4495E2E1-3129-404C-A68D-DC6467502F8EQ37612343-8353FFA3-199D-4F1B-884E-509CA4317F71Q37903903-12A2C9D3-DAD5-4108-A778-E0E1030E75E3Q38132666-8BE4A309-6CE7-4E32-B9C3-7A5523E43A95Q38253191-3A995F39-1FB1-4BBE-B921-A666DC81880FQ38635035-DF9EA55D-CDFB-4758-BC1B-054E5DB8382BQ38645642-BFC55B5F-5CAD-4B18-BD54-76BE5CE2F915Q38652479-34173B06-482E-4C0A-AD4F-09343AEA2186Q38791712-E3905503-21E3-40B0-93CF-1DEB23532C0DQ39003223-5FA43899-FF7B-4EEA-AA86-2CAD7BD65459Q39076243-9F5D2BDA-F3AD-40D9-A2A6-ACF1280BAAD8Q39210524-FB23A8C9-C854-4502-82D3-EE3857205E6FQ39570650-1B95E77A-EF7E-40FB-8577-B022720D2730Q39846889-C0D7250C-603D-4936-8866-2C9FAD16AC33Q40468989-EDC9EAC6-56A6-4B85-B5B4-F79A89F192A4Q40636446-C1B26C38-CD47-4229-88CA-E69066EEDAAB
P2860
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Risk of second primary cancer ...... lysis of 13 cancer registries.
@en
type
label
Risk of second primary cancer ...... lysis of 13 cancer registries.
@en
prefLabel
Risk of second primary cancer ...... lysis of 13 cancer registries.
@en
P2093
P50
P356
P1476
Risk of second primary cancer ...... lysis of 13 cancer registries.
@en
P2093
Carmen Martos
Elizabeth Tracey
Erich V Kliewer
Ghislaine Scelo
Jon G Jonasson
Jon M Tonita
Kee-Seng Chia
Mia Hashibe
Sharon Tamaro
Shu-Chun Chuang
P2860
P304
P356
10.1002/IJC.23798
P407
P577
2008-11-01T00:00:00Z